Literature DB >> 16458588

Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection.

Takayuki Yakushijin1, Tatsuya Kanto, Michiyo Inoue, Tsugiko Oze, Masanori Miyazaki, Ichiyo Itose, Hideki Miyatake, Mitsuru Sakakibara, Noriyoshi Kuzushita, Naoki Hiramatsu, Tetsuo Takehara, Akinori Kasahara, Norio Hayashi.   

Abstract

BACKGROUND: Dendritic cells (DCs) utilize Toll-like receptors (TLRs) to sense virus and initiate immune responses. We aimed at elucidating the roles of TLRs on DCs in hepatitis C virus (HCV) infection.
METHODS: Monocyte-derived DCs were obtained from 32 healthy volunteers (HV) and 30 chronically HCV-infected patients (CH). TLR2, TLR3 and TLR4 expressions on immature DCs were quantified by real-time quantitative RT-PCR. We stimulated DCs with specific TLR ligands and examined DC maturation, cytokine production and ability to stimulate allogeneic CD4(+) T cells.
RESULTS: TLR2 expression on immature DCs was lower in the CH group, whereas those of TLR3 or TLR4 were not different between the groups. Each TLR ligand induced DC maturation and stimulated them to release comparable levels of IL-12p70, IL-6, IL-10, TNF-alpha and IFN-beta between the groups. TLR2 and TLR4 ligands enhanced DC ability to stimulate T cell proliferation, with the degree due to the TLR2 ligand being lower in the CH group.
CONCLUSIONS: In HCV infection, the TLR2 expression on DCs is reduced and TLR2-stimulated DCs show lesser ability to proliferate T cells than healthy counterparts, suggesting that the TLR2 system is involved in HCV-induced immunopathogenesis.

Entities:  

Year:  2006        PMID: 16458588     DOI: 10.1016/j.hepres.2005.12.010

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  10 in total

1.  Do DCs influence the antiviral effect of interferon/ribavirin by changing their profile during the therapy?

Authors:  Hiroki Takahashi; Mikio Zeniya
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

2.  Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection.

Authors:  Koyo Higashitani; Tatsuya Kanto; Shoko Kuroda; Sachiyo Yoshio; Tokuhiro Matsubara; Naruyasu Kakita; Tsugiko Oze; Masanori Miyazaki; Mitsuru Sakakibara; Naoki Hiramatsu; Eiji Mita; Yasuharu Imai; Akinori Kasahara; Alato Okuno; Osamu Takikawa; Norio Hayashi; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2012-09-14       Impact factor: 7.527

3.  Downregulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with chronic hepatitis C.

Authors:  Li Kong; Kun Liu; Yu-Zhuo Zhang; Meng Jin; Bo-Rong Wu; Wei-Zhen Wang; Wei Li; Yue-Min Nan; Youhai H Chen
Journal:  Hepatol Int       Date:  2013-04-05       Impact factor: 6.047

4.  A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.

Authors:  Brendon Y Chua; Emily M Eriksson; Lorena E Brown; Weiguang Zeng; Eric J Gowans; Joseph Torresi; David C Jackson
Journal:  Vaccine       Date:  2008-04-07       Impact factor: 3.641

5.  Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis.

Authors:  David E Kaplan; Fusao Ikeda; Yun Li; Nobuhiro Nakamoto; Sutharsan Ganesan; Mary E Valiga; Frederick A Nunes; K Rajender Reddy; Kyong-Mi Chang
Journal:  J Hepatol       Date:  2008-03-07       Impact factor: 25.083

Review 6.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 7.  Hepatitis C, innate immunity and alcohol: friends or foes?

Authors:  Natalia A Osna; Murali Ganesan; Kusum K Kharbanda
Journal:  Biomolecules       Date:  2015-02-05

8.  Toll-like receptors and viruses: induction of innate antiviral immune responses.

Authors:  Angeliki Xagorari; Katerina Chlichlia
Journal:  Open Microbiol J       Date:  2008-05-14

9.  Alternate reading frame protein (F protein) of hepatitis C virus: paradoxical effects of activation and apoptosis on human dendritic cells lead to stimulation of T cells.

Authors:  Subodh Kumar Samrat; Wen Li; Shakti Singh; Rakesh Kumar; Babita Agrawal
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 10.  Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells.

Authors:  Deepa Rana; Yogesh Chawla; Sunil K Arora
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.